TALIX THERAPEUTICS FRANCE

MABDESIGN MEMBER

About us

TALIX Therapeutics, is a privately-held biotech company pioneering the next generation of immune modulators with a diversified portofolio of first-in-class therapeutic antibodies in cancers.

Know-how

pre-clinical , immuno-oncology, antibody engineering

Field of application
  • antibodies
  • immunomodulators
Therapeutic application
  • immunology
  • oncology

Expertise

  • Expression and pathway analysis of target
  • quantification of target
  • Assay development in in-vitro & in-vivo models
  • Research exploratory companion biomarkers
  • Binding & Affinity
  • Epitope mapping
  • Functional effects
  • ADCC, ADCP & CDC
  • Antigen density target
  • Internalization
  • Pharmacology & Biological activity
  • Mode of Action
  • Therapeutic efficacy
  • Engineering
  • Antibody humanization
  • Proof of concept
  • Pharmacology potency
  • in-vitro & ex-vivo models
  • in-vivo models

Category

  • Therapeutic product

Contact

  • Xavier PREVILLE
    Directeur Scientifique
  • 101 rue de Miromesnil 75008 PARIS 2ème
  • 0772161915
  • xpreville@talixtx.com